Medical University of Vienna (AKH)
Vienna, 1090, Austria
NCT Number: NCT04658836
Patients undergoing surgery of a vestibular schwannoma will be included in the study. Patients will receive triamcinolone acetonide 24h before surgery. During translabyrinthine surgery cochlear perilymph, perilymph from the semicircular canal and cerebrospinal fluid will be taken and analyzed for triamcinolone content. In patients undergoing middle fossa or retrosigmoid resection only cerebrospinal fluid will be taken and analyzed for triamcinolone acetonide level.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 1
Vienna, 1090, Austria
Patients between 18 and 90 years undergoing surgery of a vestibular schwannoma will be included in the study. Patients will be offered an application of triamcinolone acetonide intratympanically on the day before surgery.
During surgery samples will be taken to define how much triamcinolone acetonide enters into the perilymphatic fluid, the perilymph of the semicircular canals and CSF.
Patients undergoing translabyrinthine surgery will undergoing labyrinthectomy during which samples of the semicircular canal can be taken. During translabyrinthine surgery nerve monitoring will be carried out using an intracochlear electrode. Before inserting the electrode perilymph of the cochlea can be taken. Immediately after opening the dura cerebrospinal fluid will be taken. Patients undergoing middle fossa or retrosigmoid resection of the vestibular schwannoma will not undergo sampling of the perilymph. In these patients cerebrospinal fluid will be taken to determine triamcinolone acetonide levels.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intratympanic application of triamcinolone acetonide
Time frame: one day
Drug level
Medical University of Vienna
Other
Triamcinolone Acetonide Levels in Cochlear Perilymph, Lateral Canal and CSF in Patients With Vestibular Schwannomas
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05786144
Cranial Nerve Diseases, Cranial Nerve Neoplasms
Maastricht, Limburg, Netherlands
View Trial DetailsNCT04057976
Cranial Nerve Diseases, Cranial Nerve Neoplasms
London, United Kingdom
View Trial DetailsNCT02249572
Cranial Nerve Diseases, Cranial Nerve Neoplasms
Bergen, Norway
View Trial DetailsNCT04241679
Acoustic Neuroma, Asymmetric Sensorineural Hearing Loss
St Louis, Missouri, United States
View Trial Details